Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04LEK
|
||||
Former ID |
DCL000390
|
||||
Drug Name |
GSK729327
|
||||
Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Discontinued in Phase 1 | [1] | ||
Company |
GSK
|
||||
Target and Pathway | |||||
Target(s) | Glutamate receptor AMPA subtype | Target Info | Modulator | [2] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025967) | ||||
REF 2 | Clinical pipeline report, company report or official report of GlaxoSmithKline (2009). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.